4h
Yonhap News English on MSNCelltrion booth at inflammatory bowel disease research gatheringVisitors attend a presentation by South Korean pharmaceutical giant Celltrion Inc. during the 2025 European Crohn's and ...
Bradford-born magician Steven Frayne - formerly known as Dynamo - has spoken of his struggles with Crohn's disease.
A new study links mitochondrial dysfunction to Crohn’s disease, shifting how scientists approach treatment and opening doors ...
Steven Frayne, formerly known as the illusionist and magician Dynamo, said he hoped Bradford's City of Culture year would ...
Tampa Bay Lightning forward Michael Eyssimont was diagnosed with Crohn's disease eight years ago at the age of 21. Since then ...
Extraintestinal manifestations and arthralgia are significant predictors of IBD-related arthritis among patients with CD, while sacroiliitis was not associated.
Noninvasive monitoring methods, such as enterography and ultrasound, are becoming increasingly recognized as essential tools ...
A new international study published in the journal Gastroenterology has shown that the approach first developed in University ...
Thetis Pharmaceuticals LLC (“Thetis”), a clinical-stage company developing TP-317, a first-in-class, small molecule drug ...
Local philanthropists Larry Sears and Sally Zlotnick Sears awarded a “transformative” $1 million gift to the Crohn’s & ...
Many insured US patients living with IBD face challenges to health care access, which has resulted in them skipping or rationing medication.
Pediatric patients who adopted and sustained a CD exclusion diet achieved clinical remission and reported improvement in clinical symptoms and fecal calprotectin.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results